A. CANGA Et Al. , "Elevated serum osteoprotegerin levels predict in-hospital major adverse cardiac events in patients with ST elevation myocardial infarction," JOURNAL OF CARDIOLOGY , vol.60, pp.355-360, 2012
CANGA, A. Et Al. 2012. Elevated serum osteoprotegerin levels predict in-hospital major adverse cardiac events in patients with ST elevation myocardial infarction. JOURNAL OF CARDIOLOGY , vol.60 , 355-360.
CANGA, A., DURAKOĞLUGİL, M. E., ERDOĞAN, T., Kirbas, A., YILMAZ, A., ÇİÇEK, Y., ... ERGUL, E.(2012). Elevated serum osteoprotegerin levels predict in-hospital major adverse cardiac events in patients with ST elevation myocardial infarction. JOURNAL OF CARDIOLOGY , vol.60, 355-360.
CANGA, Aytun Et Al. "Elevated serum osteoprotegerin levels predict in-hospital major adverse cardiac events in patients with ST elevation myocardial infarction," JOURNAL OF CARDIOLOGY , vol.60, 355-360, 2012
CANGA, Aytun Et Al. "Elevated serum osteoprotegerin levels predict in-hospital major adverse cardiac events in patients with ST elevation myocardial infarction." JOURNAL OF CARDIOLOGY , vol.60, pp.355-360, 2012
CANGA, A. Et Al. (2012) . "Elevated serum osteoprotegerin levels predict in-hospital major adverse cardiac events in patients with ST elevation myocardial infarction." JOURNAL OF CARDIOLOGY , vol.60, pp.355-360.
@article{article, author={Aytun CANGA Et Al. }, title={Elevated serum osteoprotegerin levels predict in-hospital major adverse cardiac events in patients with ST elevation myocardial infarction}, journal={JOURNAL OF CARDIOLOGY}, year=2012, pages={355-360} }